Philippe Moulin, France
TBA TBA
Moderator of 1 Session
Session Time
15:30 - 17:00
Session Evaluation
Please click here to evaluate your knowledge. Your input is appreciated!
Session Evaluation
Option 1
[{"name":"Introduction","mode":"playlist","public":true,"info":{"id":1579,"presentation":"Introduction","session":"The role of TG-rich lipoproteins in atherosclerosis","presenter":"Philippe Moulin, France","photo":""},"playlist":[{"name":"Introduction","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/107\/Philippe Moulin - EAS20 - 1579 - Introduction.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/107\/Philippe Moulin - EAS20 - 1579 - Introduction.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/107\/28548063.jpg","data":[],"tracks":[]}]},{"name":"TG-rich lipoproteins as a risk factor","mode":"playlist","public":true,"info":{"id":1511,"presentation":"TG-rich lipoproteins as a risk factor","session":"The role of TG-rich lipoproteins in atherosclerosis","presenter":"Ruth Frikke-Schmidt, Denmark","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/619.jpg"},"playlist":[{"name":"TG-rich lipoproteins as a risk factor","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/107\/EAS 1511 .mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/107\/EAS 1511 .mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/107\/F4BEE98F.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/107\/EAS 1511 .vtt"}]},{"name":"The value of omega 3: from biology to clinical practice","mode":"playlist","public":true,"info":{"id":1512,"presentation":"The value of omega 3: from biology to clinical practice","session":"The role of TG-rich lipoproteins in atherosclerosis","presenter":"Alberto Zambon, Italy","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/550.jpg"},"playlist":[{"name":"","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/107\/Alberto Zambon - EAS 2020 - 1512 - The value of omega 3 from biology to clinical practice.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/107\/Alberto Zambon - EAS 2020 - 1512 - The value of omega 3 from biology to clinical practice.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/107\/6614D78C.jpg","data":[],"tracks":[]}]},{"name":"Position of omega 3 in Guidelines (as second choice after statins)","mode":"playlist","public":true,"info":{"id":1513,"presentation":"Position of omega 3 in Guidelines (as second choice after statins)","session":"The role of TG-rich lipoproteins in atherosclerosis","presenter":"Christie Ballantyne, United States of America","photo":""},"playlist":[{"name":"Position of omega 3 in Guidelines (as second choice after statins","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/107\/Christie M. Ballantyne MD EAS20 1513 Position of omega 3 in Guidelines (as second choice after statins.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/107\/Christie M. Ballantyne MD EAS20 1513 Position of omega 3 in Guidelines (as second choice after statins.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/107\/63228A2.jpg","data":[],"tracks":[]}]},{"name":"Case: Diabetic patient with MI - how to manage?","mode":"playlist","public":true,"info":{"id":1514,"presentation":"Case: Diabetic patient with MI - how to manage?","session":"The role of TG-rich lipoproteins in atherosclerosis","presenter":"Dirk M\u00fcller-Wieland, Germany","photo":""},"playlist":[{"name":"","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/107\/Dirk M\u00fcller-Wieland - EAS20 - 1514 - Case Diabetic patient with MI - how to manage.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/107\/Dirk M\u00fcller-Wieland - EAS20 - 1514 - Case Diabetic patient with MI - how to manage.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/107\/8AC98309.jpg","data":[],"tracks":[]}]},{"name":"Panel Discussion with Live Q&A","mode":"playlist","public":true,"info":{"id":1536,"presentation":"Panel Discussion with Live Q&A","session":"The role of TG-rich lipoproteins in atherosclerosis","presenter":"Philippe Moulin, France, Jan Boren, Sweden, Ruth Frikke-Schmidt, Denmark, Alberto Zambon, Italy, Christie Ballantyne, United States of America, Dirk M\u00fcller-Wieland, Germany","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/619.jpg"},"playlist":[{"name":"The role of TG-rich lipoproteins in atherosclerosis","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/107\/The role of TG-rich lipoproteins in atherosclerosis.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/107\/The role of TG-rich lipoproteins in atherosclerosis.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/107\/AA505DC4.jpg","data":[],"tracks":[]}]}]
{"type":2,"code":"9E32Xi02R"}
[session]
[presentation]
[presenter]
Presenter of 2 Presentations
Introduction
Session Time
15:30 - 17:00
Lecture Time
15:30 - 15:33
[{"name":"Introduction","mode":"playlist","public":true,"info":{"id":1579,"presentation":"Introduction","session":"The role of TG-rich lipoproteins in atherosclerosis","presenter":"Philippe Moulin, France","photo":""},"playlist":[{"name":"Introduction","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/107\/Philippe Moulin - EAS20 - 1579 - Introduction.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/107\/Philippe Moulin - EAS20 - 1579 - Introduction.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/107\/28548063.jpg","data":[],"tracks":[]}]}]
{"provider":"CTI","provider_live":0,"type":1,"code":"aE22Xi0te"}
[session]
[presentation]
[presenter]
Panel Discussion with Live Q&A
Session Time
15:30 - 17:00
Lecture Time
16:29 - 16:44
[{"name":"Panel Discussion with Live Q&A","mode":"playlist","public":true,"info":{"id":1536,"presentation":"Panel Discussion with Live Q&A","session":"The role of TG-rich lipoproteins in atherosclerosis","presenter":"Philippe Moulin, France, Jan Boren, Sweden, Ruth Frikke-Schmidt, Denmark, Alberto Zambon, Italy, Christie Ballantyne, United States of America, Dirk M\u00fcller-Wieland, Germany","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/619.jpg"},"playlist":[{"name":"The role of TG-rich lipoproteins in atherosclerosis","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/107\/The role of TG-rich lipoproteins in atherosclerosis.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/107\/The role of TG-rich lipoproteins in atherosclerosis.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/107\/AA505DC4.jpg","data":[],"tracks":[]}]}]
{"provider":"CTI","provider_live":0,"type":1,"code":"7E22Xi0su"}
[session]
[presentation]
[presenter]
